Skip to main content

Casper Marc N's Form 4 filing

Thermo Fisher Scientific Inc. (TMO) · filed May 4, 2022

Accession no.
0001127602-22-013250
Filed
May 4, 2022
Trade date
Mar 17-May 2, 2022
Filing delay
48 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 17 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.46M. It was filed 48 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Casper Marc NCIK 0001216055Director, Officer (Chairman & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 17, 2022Common StockGGiftDisposed−2,000$0.00$0186,372.53Direct
Mar 18, 2022Common StockGGiftDisposed−3,000$0.00$0183,372.53Direct
May 2, 2022Common StockMOption exerciseAcquired+10,000$129.77+$1,297,700193,372.53Direct
May 2, 2022Common StockSSaleDisposed−300$536.90F2−$161,070193,072.53Direct
May 2, 2022Common StockSSaleDisposed−500$538.04F3−$269,020192,572.53Direct
May 2, 2022Common StockSSaleDisposed−540$539.05F4−$291,087192,032.53Direct
May 2, 2022Common StockSSaleDisposed−400$540.42F5−$216,168191,632.53Direct
May 2, 2022Common StockSSaleDisposed−300$541.75F6−$162,525191,332.53Direct
May 2, 2022Common StockSSaleDisposed−600$543.33F7−$325,998190,732.53Direct
May 2, 2022Common StockSSaleDisposed−2,095$545.20F8−$1,142,194188,637.53Direct
May 2, 2022Common StockSSaleDisposed−1,025$545.98F9−$559,629.5187,612.53Direct
May 2, 2022Common StockSSaleDisposed−1,200$547.46F10−$656,952186,412.53Direct
May 2, 2022Common StockSSaleDisposed−900$548.15F11−$493,335185,512.53Direct
May 2, 2022Common StockSSaleDisposed−480$549.24F12−$263,635.2185,032.53Direct
May 2, 2022Common StockSSaleDisposed−1,000$550.29F13−$550,290184,032.53Direct
May 2, 2022Common StockSSaleDisposed−460$551.40F14−$253,644183,572.53Direct
May 2, 2022Common StockSSaleDisposed−200$552.51F15−$110,502183,372.53Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 2, 2022Common StockMOption exerciseDisposed−10,000$0.00$0118,100Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $536.29 to $537.24, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14) and (15) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $537.59 to $538.42, inclusive.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $538.67 to $539.46, inclusive.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $540.17 to $540.75, inclusive.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $541.40 to $542.01, inclusive.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.84 to $543.75, inclusive.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $544.54 to $545.51, inclusive.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $545.56 to $546.37, inclusive.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.80 to $547.77, inclusive.

Referenced by the price of 1 transaction in Table I.

F11

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.91 to $548.43, inclusive.

Referenced by the price of 1 transaction in Table I.

F12

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.94 to $549.84, inclusive.

Referenced by the price of 1 transaction in Table I.

F13

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.97 to $550.65, inclusive.

Referenced by the price of 1 transaction in Table I.

F14

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.11 to $551.88, inclusive.

Referenced by the price of 1 transaction in Table I.

F15

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $552.41 to $552.60, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)